CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.
Jaeckle, Kurt A, Ballman, Karla V, van den Bent, Martin, Giannini, Caterina, Galanis, Evanthia, Brown, Paul D, Jenkins, Robert B, Cairncross, J Gregory, Wick, Wolfgang, Weller, Michael, Aldape, KennetJournal:
Neuro-Oncology
DOI:
10.1093/neuonc/noaa168
Date:
July, 2020
File:
PDF, 886 KB
2020
File converter
More search results
More benefits 
